1-2 of 2
Jan van Lunzen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Improved outcome with rituximab in patients with HIV-associated multicentric Castleman disease

Clinical Trials & Observations
Christian Hoffmann, Holger Schmid, Markus Müller, Christian Teutsch, Jan van Lunzen, Stefan Esser, Timo Wolf, Christoph Wyen, Michael Sabranski, Heinz-August Horst, Stefan Reuter, Martin Vogel, Hans Jäger, Johannes Bogner, Keikawus Arasteh
Journal: Blood
Blood (2011) 118 (13): 3499–3503.
https://doi.org/10.1182/blood-2011-02-333633
Published: 2011
Journal Articles

Specific Chemotherapy and Rituximab In HIV-Infected Patients with Burkitt's Leukemia or Lymphoma. Results of a German-Spanish Study and Analysis of Prognostic Factors

Josep-Maria Ribera, MD, Christoph Wyen, MD, Mireia Morgades, PhD, Christian Hoffmann, MD, Albert Oriol, MD, Gerd Fätkenheuer, MD, Carlos Grande, MD, Markus Mueller, MD, Jordi Esteve, MD, Jan-Christian Wasmuth, MD, Eloy Del Potro, MD, Jan van Lunzen, MD, Salut Brunet, MD, Heribert Knechten, MD, Lourdes Escoda, Angela Hammond, MD, Nuria Alonso, MD, Marcus Hentrich, MD, Ferran Vall-llovera, MD, Christoph Mayr, MD, Montserrat Perez, MD, Jan Thoden, MD, Olga Garcia, PhD, Thomas Sternfeld, MD, Timo Wolf, MD, Miguel-Angel Sanz, MD, Dieter Hoelzer, MD
Journal: Blood
Blood (2010) 116 (21): 3944.
https://doi.org/10.1182/blood.V116.21.3944.3944
Published: 2010